BIODESIX INC. - COMMON STOCK

Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types

23 Apr 2025 05:00:00 By Nasdaq GlobeNewswire

Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results

03 Mar 2025 15:01:00 By Nasdaq GlobeNewswire

Biodesix to Present at TD Cowen 45th Annual Health Care Conference

26 Feb 2025 05:00:00 By Nasdaq GlobeNewswire

Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

18 Feb 2025 05:00:00 By Nasdaq GlobeNewswire

Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)

10 Jan 2025 05:00:00 By Nasdaq GlobeNewswire

Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study

07 Jan 2025 05:00:00 By Nasdaq GlobeNewswire

Biodesix Announces Third Quarter 2024 Results and Highlights

01 Nov 2024 05:00:00 By Nasdaq GlobeNewswire

Biodesix to Participate in Three Investor Conferences in November

29 Oct 2024 05:00:00 By Nasdaq GlobeNewswire